186 related articles for article (PubMed ID: 4193237)
1. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
2. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
3. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
4. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
5. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
6. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
7. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
8. [LATS production by lymphocyte culture].
Fukuchi M
Nihon Naibunpi Gakkai Zasshi; 1969 Oct; 45(7):766-77. PubMed ID: 5394607
[No Abstract] [Full Text] [Related]
9. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
10. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
11. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
12. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
Bech K
Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
[No Abstract] [Full Text] [Related]
13. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
[No Abstract] [Full Text] [Related]
14. On the mechanism of the McKenzie bioassay.
Florsheim WH; Williams AD; Schönbaum E
Endocrinology; 1970 Nov; 87(5):881-8. PubMed ID: 5536603
[No Abstract] [Full Text] [Related]
15. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
Brown J; Ensor J; Munro DS
Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
[No Abstract] [Full Text] [Related]
16. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
17. [Therapy of acute thyrotoxic attacks].
Laroche C; Grégoire J; Turpin G
Presse Med (1893); 1968 Dec; 76(48):2283-5. PubMed ID: 4181047
[No Abstract] [Full Text] [Related]
18. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
19. Humoral immunity in Graves' disease.
McKenzie JM; Zakarija M; Sato A
Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
[No Abstract] [Full Text] [Related]
20. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]